Table 4:
Exposure to Project Shikamana elements and HIV outcomes at follow-up within the intervention arm
| Prevention outcomes | Prevention exposure level | |||
|---|---|---|---|---|
| (n=120 incidence; n=211 condom use in the intervention community: Ilula) | Low (0=Ref) | Medium (1–2) | High (3–6) | P-Value highest exposure |
| HIV incidence | 2 (9.5%) | 2 (4.2%) | 2 (3.9%) | |
| RR (95% CI) | 1.00 | 0.41 (0.05–3.18) | 0.39 (0.05–3.00) | 0.362 |
| Inconsistent condom use | 20 (54.1%) | 41 (48.8%) | 31 (34.4%) | |
| RR (95% CI) | 1.00 | 0.90 (0.62–1.31) | 0.64 (0.42–0.96) | 0.032 |
| Care and treatment outcomes | Care and treatment exposure level | |||
| (n=91 for all care outcomes in the intervention community: Ilula) | Low (0–1=Ref) | Medium (2–5) | High (6–9) | P-Value highest exposure |
| Currently in care | 9 (45.0%) | 33 (78.6%) | 28 (96.6%) | |
| RR (95% CI) | 1.00 | 1.75 (1.05–2.91) | 2.15 (1.31–3.51) | 0.002 |
| Currently on ART | 10 (50.0%) | 36 (85.7%) | 28 (96.6%) | |
| RR (95% CI) | 1.00 | 1.71 (1.08–2.71) | 1.93 (1.24–3.02) | 0.004 |
| ART adherence last 4 days | 8 (40.0%) | 31 (73.8%) | 26 (89.7%) | |
| RR (95% CI) | 1.00 | 1.84 (1.04–3.26) | 2.24 (1.29–3.90) | 0.004 |
| Viral load <400 copies/mL | 6 (30.0%) | 20 (47.6%) | 20 (69.0%) | |
| RR (95% CI) | 1.00 | 1.59 (0.75–3.34) | 2.30 (1.12–4.71) | 0.023 |